Skip to content

Clinical trials

Head and Neck Neoplasms trials in Canada with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Head and Neck Neoplasms Phase: Not applicable Country / region: Canada Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20081
20092
20101
20123
20134
20142
20153
20163
20174
20186
20193
20202
20212
20221
20233
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Unknown status7
Recruiting6
Terminated4
Active, not recruiting1
Suspended1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Health Network, Toronto12
University of Alberta7
University of Calgary7
Sunnybrook Health Sciences Centre4
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's3
AHS Cancer Control Alberta2
University of British Columbia2
Varian, a Siemens Healthineers Company2
Western University, Canada2
Centre hospitalier de l'Université de Montréal (CHUM)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Head and Neck Neoplasms46
Breast Neoplasms5
Squamous Cell Carcinoma of Head and Neck5
Deglutition Disorders3
Neoplasms3
Carcinoma, Squamous Cell2
Lymphoma2
Mouth Neoplasms2
Oropharyngeal Neoplasms2
Trismus2

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.